HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹1,590 Cr | ₹1,621 Cr | ₹1,446 Cr | ₹1,305 Cr | ₹1,091 Cr |
What is the latest Total Non-Current Assets ratio of HIKAL ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹1,590 Cr |
| Mar2024 | ₹1,621 Cr |
| Mar2023 | ₹1,446 Cr |
| Mar2022 | ₹1,305 Cr |
| Mar2021 | ₹1,091 Cr |
How is Total Non-Current Assets of HIKAL Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,590 Cr | -1.93 | |
| Mar2024 | ₹1,621 Cr | 12.05 | |
| Mar2023 | ₹1,446 Cr | 10.86 | |
| Mar2022 | ₹1,305 Cr | 19.64 | |
| Mar2021 | ₹1,091 Cr | - | |
Compare Total Non-Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,712.6 Cr | 3.4% | 18.2% | -38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 3.4% |
18.2% |
-38% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses